Results 1 to 10 of about 5,749 (116)
Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
American Journal of Ophthalmology Case Reports, 2020 Purpose: To report the first case of cystoid macular edema (CME) induced by nabpaclitaxel treated with intravitreal dexamethasone implant. Observations: A 67 year-old man diagnosed with unresectable pancreatic cancer presented with decreased vision in ...
Barbara Burgos-Blasco +3 more
doaj +3 more sources
Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia [PDF]
Journal of Ophthalmic Inflammation and InfectionPurpose To report the use of Fluocinolone intravitreal implant (Iluvien) for the treatment of persistent cystoid macular edema (CME) due to immune recovery uveitis syndrome in a patient with previous cytomegalovirus retinitis and acute myeloid leukemia ...
JM Cachero Rodríguez +3 more
doaj +2 more sources
Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review [PDF]
Ophthalmology and TherapyDiabetic macular edema (DME) is a potential complication of diabetic retinopathy (DR) and a leading cause of DR-related impairment of central vision. The pathogenesis of DME is complex and multifactorial.
Riccardo Sacconi +8 more
doaj +2 more sources
Safety and Efficacy of Dexamethasone Intravitreal Implant Given Either First-Line or Second-Line in Diabetic Macular Edema [PDF]
Patient Preference and Adherence, 2023 Vincenzo Scorcia +2 more
exaly +2 more sources
Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis
American Journal of Ophthalmology Case Reports, 2021 Purpose: To report the first patient with ocular toxoplasmosis treated with a slow-release biodegradable intravitreal clindamycin implant. Observations: A 39-year-old human immunodeficiency virus (HIV)-positive woman with recurrent toxoplasmic ...
Rodrigo Jorge, MD, PhD +6 more
doaj +1 more source
American Journal of Ophthalmology Case Reports, 2020 Purpose: To describe a case of spontaneous anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
Manal Alzaabi +2 more
doaj +1 more source
An Experience with Intravitreal Dexamethasone Implant for Uveitic Macular Oedema
Journal of Nepal Health Research Council, 2021 Intravitreal steroid implants are the latest trend for uveitis macular oedema treatment. Dexamethasone intravitreal implants are new in our contexts but we report 2 cases of uveitic cystoid macular oedema where this implant proved very useful in the ...
Ranju Kharel (Sitaula) +1 more
doaj +1 more source
The Pan-American Journal of Ophthalmology, 2022 To report the use of intravitreal dexamethasone implant and its short-term efficacy in a pediatric patient with Coats' disease. A 7-year-old patient was referred to the clinic because of decreased visual acuity in the right eye of 10-month duration. Best-
Salcedo Hugo Ricardo +2 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Background: To compare the efficacy and safety of advanced intravitreal therapeutic regimens, including a dexamethasone implant at 350 and 700 μg; a fluocinolone acetonide (FA) implant, 0.2 µg/day, 0.59 and 2.1 mg; intravitreal bevacizumab, 1.25 mg ...
Weiting Liao +4 more
doaj +1 more source
Офтальмохирургия, 2020 Purpose. To evaluate the effectiveness of intravitreal injection of biodegradable intravitreal implant containing dexamethasone (Ozurdex) in patients with resistant diabetic macular edema (DME).Material and methods. The study was conducted of 24 patients
M. M. Bikbov +4 more
doaj +1 more source